Quantitative clinical pharmacology: Making paradigm shifts a reality

Journal of Clinical Pharmacology

Volumn 46, Issue 9, 2006, Pages 966-967

  Krishna, Rajesh ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID;

ASTHMA; CLINICAL PHARMACOLOGY; DRUG ACTIVITY; DRUG DESIGN; DRUG MARKETING; DRUG RESEARCH; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; DRUG TARGETING; EDITORIAL; QUANTITATIVE ANALYSIS; RISK BENEFIT ANALYSIS; TREATMENT INDICATION;

DRUG DESIGN; PHARMACOLOGY, CLINICAL; RISK FACTORS;

EID: 33747084052     PISSN: 00912700     EISSN: 15524604     Source Type: Journal    
DOI: 10.1177/0091270006292978     Document Type: Editorial

References (2)

1. Challenge and opportunity on the critical path to new medical products, US Food and Drug Administration, 2004. Available at: http://www.fda.gov/oc/ initiatives/criticalpath/whitepaper.html. Accessed July 12, 2006.
2. Innovative medicines for Europe, EFPIA, 2004. Available at: http://ec.europa.eu/research/fp6/index_en.cfm?p=1_innomed. Accessed July 12, 2006.